We support efforts that modernize mental health care through evidence-based thinking, responsible regulation, and open dialogue between science, policy, and society.
Our involvement focuses on strengthening frameworks that enable safe, equitable access to emerging treatments, including psychedelic-assisted therapies.
The aim is to contribute to systems that are both humane and scientifically grounded, working with policymakers, researchers, and advocacy organizations to ensure new treatments are integrated responsibly and made available to those who can benefit.
Evidence-based policy development
Supporting research that informs regulatory frameworks for psychedelic medicine, ensuring patient safety while enabling access.
Education and access initiatives
Working to destigmatize mental health treatment and expand equitable access to evidence-based care.
Policy partnerships
Collaboration with European and global mental health initiatives to advance responsible innovation.